Amphastar Pharmaceuticals (AMPH) Goodwill & Intangibles (2013 - 2026)

Amphastar Pharmaceuticals' Goodwill & Intangibles history runs 14 years deep, the most recent figure standing at $559.6 million for Q1 2026.

• On a quarterly basis, Goodwill & Intangibles fell 4.26% year-over-year to $559.6 million in Q1 2026; TTM through Mar 2026 was $559.6 million, a 4.26% decrease from a year earlier, with the FY2025 full-year figure at $566.0 million, down 4.18% from the prior year.
• Goodwill & Intangibles retreated to $559.6 million in Q1 2026 per AMPH's latest filing, from $566.0 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $625.6 million in Q2 2023 and bottomed at $37.0 million in Q3 2022.
• The 5-year median for Goodwill & Intangibles is $578.5 million (2025), against an average of $429.4 million.
• Across the five-year window, Goodwill & Intangibles slipped 5.87% in 2022 and jumped 1572.25% in 2023, its largest moves.
• Year by year, Goodwill & Intangibles stood at $37.3 million in 2022, then soared by 1544.31% to $613.3 million in 2023, then decreased by 3.69% to $590.7 million in 2024, then decreased by 4.18% to $566.0 million in 2025, then declined by 1.12% to $559.6 million in 2026.
• Per Business Quant, the three latest AMPH Goodwill & Intangibles figures stand at $559.6 million (Q1 2026), $566.0 million (Q4 2025), and $572.2 million (Q3 2025).